Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
Background: Efforts to understand the impact of SARS-CoV-2 variants, vaccine status, and treatment on the development and persistence of Long COVID have intensified. Methods: We report 4 sequential cases from a post-COVID cohort study demonstrating variability in outcomes following differentially t...
Saved in:
Main Authors: | Michael Peluso (Author), Khamal Anglin (Author), Matthew S. Durstenfeld (Author), Jeffrey N. Martin (Author), J. Daniel Kelly (Author), Priscilla Y. Hsue (Author), Timothy J. Henrich (Author), Steven G. Deeks (Author) |
---|---|
Format: | Book |
Published: |
Case Western Reserve University,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inpatient remdesivir versus nirmatrelvir-ritonavir in the progression of COVID-19
by: Dimple Patel, et al.
Published: (2023) -
Dosing recommendation of nirmatrelvir/ritonavir using an integrated population pharmacokinetic analysis
by: Phylinda L. S. Chan, et al.
Published: (2023) -
Bioequivalence study of generic nirmatrelvir in healthy volunteers
by: R. A. Oseshnyuk, et al.
Published: (2023) -
Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19
by: Jiayue Lu, et al.
Published: (2023) -
Nirmatrelvir, a novel medication for COVID-19 treatment
by: Mohammad Reza Hajian, et al.
Published: (2023)